Skip left side navigation and go to content

NIH State of the Science Symposium on Myelodysplastic Syndromes (MDS)

Welcome


Wednesday, September 7, 2011


Location:

Lister Hill Conference Center (Building 38A)
National Institutes of Health
8600 Rockville Pike
Bethesda, MD 20892

Time:

7:00 a.m. - 6:00 p.m.

Thursday, September 8, 2011


Location:

Lister Hill Conference Center (Building 38A)
National Institutes of Health
8600 Rockville Pike
Bethesda, MD 20892

Time:

7:00 a.m. - 1:00 p.m.

Mark your calendar now and plan to attend the NIH State of the Science Symposium on Myelodysplastic Syndromes (MDS). The Symposium will be held at Lister Hill Auditorium (Building 38A) on the NIH campus in Bethesda, Maryland on September 7-8, 2011. This one and one half day symposium will bring together clinicians and basic scientists to discuss the biological basis of MDS, approaches to risk stratification and prediction of disease progression, and molecular targets for therapeutic interventions. The emphasis of each didactic session will be to review the current knowledge of the field and to summarize recent discoveries. Each didactic session will be followed by 30 to 45 minutes of discussion.

The goal of this symposium is to identify knowledge gaps and challenges in the field, and the most promising areas for future research to address critical unmet needs of people with this syndrome. The planning committee includes members from the NHLBI, NCI, NIDDK and NIA.


Confirmed Speakers:

Hal E. Broxmeyer, Ph.D., (Co-Chair), Indiana University School of Medicine

Pierre Fenaux, M.D., (Co-Chair), Hôpital Avicenne, Universite Paris (France)

Peter D. Aplan, M.D., National Cancer Institute

Monica Bessler, M.D., Ph.D., The Children's Hospital of Philadelphia

Benjamin L. Ebert, M.D., Ph.D., Brigham and Women's Hospital

Guillermo Garcia-Manero, M.D., MD Anderson Cancer Center

Timothy Graubert, M.D., Washington University in St. Louis

Steven Gore, M.D., Johns Hopkins University

Eva Hellstrom-Lindberg, M.D., Ph.D., Karolinska Institutet (Sweden)

James G. Herman, M.D., Johns Hopkins University School of Medicine

Marshall S. Horwitz, M.D., Ph.D., University of Washington

Sten E. Jacobsen, M.D., Ph.D., Weatherall Institute for Molecular Medicine (United Kingdom)

Jaroslaw P. Maciejewski, M.D., Ph.D., Cleveland Clinic

Ari M. Melnick, M.D., Weill Cornell Medical College

Stephen D. Nimer, M.D., Memorial Sloan-Kettering Cancer Center

David Scadden, M.D., Massachusetts General Hospital and Harvard Stem Cell Institute

Susan B. Shurin, M.D., National Heart, Lung, and Blood Institute

Mathew J. Walter, M.D., Washington University in St. Louis

Cheryl L. Willman, M.D., University of New Mexico Cancer Center


For further information, please contact:

Ms. Della Claiborne
Email: claiborned@od.nih.gov
Phone: 301-594-4607

Ms. Petronella Barrow
Email: barrowp@nhlbi.nih.gov
Phone: 301-435-0080







Last Updated January 2012




Skip footer links and go to content
Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon